For early-stage cervical cancer, non-radical surgery (simple hysterectomy or cone biopsy plus pelvic lymphadenectomy) appears safe with no lasting negative impact on quality of life, according […]

(Reuters) -Bristol Myers Squibb said on Wednesday a combination of Opdivo and Yervoy met the main goal of a late-stage study evaluating it as an initial […]

Widely considered the father of cancer immunotherapy, Steven A. Rosenberg, MD, PhD, FAACR, has spent nearly 50 years analyzing the link between patients’ immune reaction and […]

TOPLINE: Secondary cancers were flagged in 4.3% of all adverse event reports among patients who received CAR T therapy, with T-cell malignancies comprising only 0.15% of […]

The US Food and Drug Administration has granted ponatinib (Iclusig, Takeda) accelerated approval for use with chemotherapy in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic […]

ChatGPT can accurately answer common questions pertaining to genetic testing and counseling for gynecologic cancers but stumbles when asked to provide the appropriate treatment option, according […]

The head and neck cancer community has been working to de-escalate treatment for human papillomavirus (HPV)–associated oropharynx squamous cell carcinomas for several years in hopes of […]

Cells in the human body chat with each other all the time. One major way they communicate is by releasing tiny spheres called exosomes. These carry […]

Adding an immune checkpoint inhibitor to platinum-based chemotherapy resulted in a more than 1-year gain in median overall survival for women with primary advanced or recurrent […]